Cargando…

SUSTAINED EFFICACY OF INCOBOTULINUMTOXINA FOLLOWING REPEATED INJECTIONS FOR UPPER-LIMB POST-STROKE SPASTICITY: A POST HOC ANALYSIS

OBJECTIVE: This post hoc analysis assessed the impact of repeated incobotulinumtoxinA injections on muscle tone, disability, and caregiver burden in adults with upper-limb post-stroke spasticity. DESIGN: Data from the double-blind, placebo-controlled main period and three open-label extension cycles...

Descripción completa

Detalles Bibliográficos
Autores principales:	KAŇOVSKÝ, Petr, ELOVIC, Elie P., MUNIN, Michael C., HANSCHMANN, Angelika, PULTE, Irena, ALTHAUS, Michael, HIERSEMENZEL, Reinhard, MARCINIAK, Christina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Foundation for Rehabilitation Information 2020
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772361/ https://www.ncbi.nlm.nih.gov/pubmed/33112408 http://dx.doi.org/10.2340/16501977-2760

Ejemplares similares

Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis
por: Kaňovský, Petr, et al.
Publicado: (2021)

Randomized, placebo‐controlled trial of incobotulinumtoxina for upper‐limb post‐stroke spasticity
por: Elovic, Elie Paul, et al.
Publicado: (2015)

IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study
por: Marciniak, Christina, et al.
Publicado: (2018)

Safety and efficacy of repeat long-term incobotulinumtoxinA treatment for lower limb or combined upper/lower limb spasticity in children with cerebral palsy
por: Kaňovský, Petr, et al.
Publicado: (2022)

IncobotulinumtoxinA for the treatment of lower-limb spasticity in children and adolescents with cerebral palsy: A phase 3 study(1)
por: Heinen, Florian, et al.
Publicado: (2021)

Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults
por: Jost, Wolfgang H., et al.
Publicado: (2023)

Spasticity-related pain in children/adolescents with cerebral palsy. Part 2: IncobotulinumtoxinA efficacy results from a pooled analysis
por: Bonfert, Michaela, et al.
Publicado: (2023)

Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects
por: Masakado, Yoshihisa, et al.
Publicado: (2022)

Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis
por: Berweck, Steffen, et al.
Publicado: (2022)

Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE)
por: Masakado, Yoshihisa, et al.
Publicado: (2020)

Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
por: Wissel, Jörg, et al.
Publicado: (2021)

Sustained efficacy and safety of repeated incobotulinumtoxinA (Xeomin(®)) injections in blepharospasm
por: Truong, Daniel D., et al.
Publicado: (2013)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
por: Fheodoroff, Klemens, et al.
Publicado: (2020)

Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb
por: Veverka, Tomáš, et al.
Publicado: (2019)

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
por: Wissel, Jörg, et al.
Publicado: (2017)

Spasticity-related pain in children/adolescents with cerebral palsy. Part 1: Prevalence and clinical characteristics from a pooled analysis
por: Heinen, Florian, et al.
Publicado: (2022)

A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin(®)) in cervical dystonia
por: Evidente, Virgilio Gerald H., et al.
Publicado: (2013)

IncobotulinumtoxinA for Post-stroke Upper Limb Spasticity in Neutralizing Antibody-positive Patients after Botulinum Toxin Therapy: A Report of Two Cases
por: Masakado, Yoshihisa, et al.
Publicado: (2022)

Cortical somatosensory processing after botulinum toxin therapy in post-stroke spasticity
por: Veverka, Tomáš, et al.
Publicado: (2021)

Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity
por: Santamato, Andrea
Publicado: (2016)

BENEFIT AND SAFETY OF INCOBOTULINUMTOXINA FOR EARLY MANAGEMENT OF POST-STROKE SPASTICITY IN A PATIENT WITH SARS-COV-2: A CASE REPORT
por: Cordero-GarcÍa, Carlos, et al.
Publicado: (2021)

Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
por: Jost, Wolfgang H, et al.
Publicado: (2015)

Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI
por: Berweck, Steffen, et al.
Publicado: (2021)

A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols
por: Chisari, Clara Grazia, et al.
Publicado: (2023)

“Appropriate Treatment” and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units
por: Ianieri, Giancarlo, et al.
Publicado: (2018)

Effect of post-stroke spasticity on voluntary movement of the upper limb
por: Lackritz, Hadar, et al.
Publicado: (2021)

Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis
por: Albanese, Alberto, et al.
Publicado: (2023)

The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021)

IncobotulinumtoxinA for the treatment of spasticity in children with cerebral palsy – a retrospective case series focusing on dosing and tolerability
por: León-Valenzuela, Angel, et al.
Publicado: (2020)

Local dynamic stability of the lower-limb as a means of post-hoc injury classification
por: Larson, Jacob, et al.
Publicado: (2021)

External location of touch is constructed post-hoc based on limb choice
por: Maij, Femke, et al.
Publicado: (2020)

Profile of Xeomin(®) (incobotulinumtoxinA) for the treatment of blepharospasm
por: Park, Juwan, et al.
Publicado: (2011)

Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study
por: Dressler, Dirk, et al.
Publicado: (2015)

Comparing the efficacy of botulinum toxin with tizanidine in upper limb post stroke spasticity
por: Yazdchi, Mohammad, et al.
Publicado: (2013)

Post-stroke Upper Limb Spasticity Incidence for Different Cerebral Infarction Site
por: Jin, Yi, et al.
Publicado: (2018)

Patient Registry of Spasticity Care World: Data Analysis Based on Physician Experience
por: Esquenazi, Alberto, et al.
Publicado: (2017)

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
por: Wissel, Jörg, et al.
Publicado: (2020)

The Effect of Repeated Botulinum Toxin A Therapy Combined with Intensive Rehabilitation on Lower Limb Spasticity in Post-Stroke Patients
por: Hara, Takatoshi, et al.
Publicado: (2018)

Long‐Term Observational Results from the ASPIRE Study: OnabotulinumtoxinA Treatment for Adult Lower Limb Spasticity
por: Esquenazi, Alberto, et al.
Publicado: (2021)

Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
por: Gracies, Jean‐Michel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kpjkuut6rllbei9er1amf86ti1